A Single Center, Open-label, Randomized, Four-Sequence, Four-period Crossover Study to Investigate Food Effect on the Pharmacokinetics of Single Dose of Volitinib in Healthy Subjects
Latest Information Update: 06 Nov 2014
At a glance
- Drugs Savolitinib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Hutchison MediPharma
- 29 Oct 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 27 Dec 2013 New trial record